Global Cartilage Regeneration Technology Market
Global Cartilage Regeneration Technology Market

Cartilage Regeneration Technology Comprehensive Study by Application (Hyaline Cartilage, Fibrocartilage), Treatment (Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds, Cell-free Composites)), End Use (Hospitals, Specialty Clinics), Portion (Knee, Hip, Ankle and Foot, Other) Players and Region - Global Market Outlook to 2026

Cartilage Regeneration Technology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 202 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Cartilage Regeneration Technology Market Overview:
Cartilage that has been weakened by trauma has a reduced ability to heal. Palliative care with arthroscopic débridement and lavage, reparative treatment with marrow-stimulation procedures (e.g., microfracture), and restorative treatment, including osteochondral grafting and autologous chondrocyte implantation, are currently used to treat minor chondral defects. Various cell types, including chondrocytes, pluripotent stem cells, and mesenchymal stem cells, can be used to regenerate cartilage. Proteins, sugars, synthetic fabrics, and hybrid polymers are examples of common scaffolding materials. Scaffolds may be knit, spun into nanofibers, or made into hydrogels. Many surgical options for treating chondral and osteochondral lesions have been advocated and practiced over the last three decades. While some methods are now possible for long-term effects, many others have advanced to deliver similar results and less complications. This hasfacilitated the growth in demand for advance Cartilage Regeneration Technology.

Growth Drivers
  • Prevalence of Osteoarthritis
  • Increasing Research & Development in Cartilage Regeneration Technology

Market Trends
  • Emergence of Advance Regeneration Procedures

Roadblocks
  • Lack of Trained Professionals
  • Expensive Procedures

Opportunities
  • Increasing Demand Across Emerging Regions

Challenges
  • Skewed Player Distribution


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are DePuy Synthes (United States), Smith & Nephew plc (United Kingdom), Zimmer Biomet (United States), CONMED Corporation (United States), Stryker Corporation (United States) and Vericel Corporation (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Cartilage Regeneration Technology market by 2026. Considering Market by Treatment, the sub-segment i.e. Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors) will boost the Cartilage Regeneration Technology market. Considering Market by End Use, the sub-segment i.e. Hospitals will boost the Cartilage Regeneration Technology market. Considering Market by Portion, the sub-segment i.e. Knee will boost the Cartilage Regeneration Technology market.

Latest Market Insights:


On 12th December, 2018 - Anika Therapeutics, Inc. (Leading Integrated Orthopedic and Regenerative Medicines Company), Announced Its Plans to Showcase Its Orthobiologics Franchise, Including HYALOFAST, At the International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting in Milan, Italy.

What Can be Explored with the Cartilage Regeneration Technology Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Cartilage Regeneration Technology Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Cartilage Regeneration Technology
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cartilage Regeneration Technology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cartilage Regeneration Technology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Cartilage Regeneration Technology Manufacturers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Application
  • Hyaline Cartilage
  • Fibrocartilage
By Treatment
  • Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors)
  • Non-cell-based (Tissue Scaffolds, Cell-free Composites)

By End Use
  • Hospitals
  • Specialty Clinics

By Portion
  • Knee
  • Hip
  • Ankle and Foot
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Osteoarthritis
      • 3.2.2. Increasing Research & Development in Cartilage Regeneration Technology
    • 3.3. Market Challenges
      • 3.3.1. Skewed Player Distribution
    • 3.4. Market Trends
      • 3.4.1. Emergence of Advance Regeneration Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cartilage Regeneration Technology, by Application, Treatment, End Use, Portion and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cartilage Regeneration Technology (Value)
      • 5.2.1. Global Cartilage Regeneration Technology by: Application (Value)
        • 5.2.1.1. Hyaline Cartilage
        • 5.2.1.2. Fibrocartilage
      • 5.2.2. Global Cartilage Regeneration Technology by: Treatment (Value)
        • 5.2.2.1. Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors)
        • 5.2.2.2. Non-cell-based (Tissue Scaffolds, Cell-free Composites)
      • 5.2.3. Global Cartilage Regeneration Technology by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Specialty Clinics
      • 5.2.4. Global Cartilage Regeneration Technology by: Portion (Value)
        • 5.2.4.1. Knee
        • 5.2.4.2. Hip
        • 5.2.4.3. Ankle and Foot
        • 5.2.4.4. Other
      • 5.2.5. Global Cartilage Regeneration Technology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Cartilage Regeneration Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DePuy Synthes (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Smith & Nephew plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Zimmer Biomet (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CONMED Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vericel Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Cartilage Regeneration Technology Sale, by Application, Treatment, End Use, Portion and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cartilage Regeneration Technology (Value)
      • 7.2.1. Global Cartilage Regeneration Technology by: Application (Value)
        • 7.2.1.1. Hyaline Cartilage
        • 7.2.1.2. Fibrocartilage
      • 7.2.2. Global Cartilage Regeneration Technology by: Treatment (Value)
        • 7.2.2.1. Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors)
        • 7.2.2.2. Non-cell-based (Tissue Scaffolds, Cell-free Composites)
      • 7.2.3. Global Cartilage Regeneration Technology by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Specialty Clinics
      • 7.2.4. Global Cartilage Regeneration Technology by: Portion (Value)
        • 7.2.4.1. Knee
        • 7.2.4.2. Hip
        • 7.2.4.3. Ankle and Foot
        • 7.2.4.4. Other
      • 7.2.5. Global Cartilage Regeneration Technology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cartilage Regeneration Technology: by Application(USD Million)
  • Table 2. Cartilage Regeneration Technology Hyaline Cartilage , by Region USD Million (2015-2020)
  • Table 3. Cartilage Regeneration Technology Fibrocartilage , by Region USD Million (2015-2020)
  • Table 4. Cartilage Regeneration Technology: by Treatment(USD Million)
  • Table 5. Cartilage Regeneration Technology Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors) , by Region USD Million (2015-2020)
  • Table 6. Cartilage Regeneration Technology Non-cell-based (Tissue Scaffolds, Cell-free Composites) , by Region USD Million (2015-2020)
  • Table 7. Cartilage Regeneration Technology: by End Use(USD Million)
  • Table 8. Cartilage Regeneration Technology Hospitals , by Region USD Million (2015-2020)
  • Table 9. Cartilage Regeneration Technology Specialty Clinics , by Region USD Million (2015-2020)
  • Table 10. Cartilage Regeneration Technology: by Portion(USD Million)
  • Table 11. Cartilage Regeneration Technology Knee , by Region USD Million (2015-2020)
  • Table 12. Cartilage Regeneration Technology Hip , by Region USD Million (2015-2020)
  • Table 13. Cartilage Regeneration Technology Ankle and Foot , by Region USD Million (2015-2020)
  • Table 14. Cartilage Regeneration Technology Other , by Region USD Million (2015-2020)
  • Table 15. South America Cartilage Regeneration Technology, by Country USD Million (2015-2020)
  • Table 16. South America Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 17. South America Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 18. South America Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 19. South America Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 20. Brazil Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 21. Brazil Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 22. Brazil Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 23. Brazil Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 24. Argentina Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 25. Argentina Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 26. Argentina Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 27. Argentina Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 28. Rest of South America Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 30. Rest of South America Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 31. Rest of South America Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 32. Asia Pacific Cartilage Regeneration Technology, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 35. Asia Pacific Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 36. Asia Pacific Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 37. China Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 38. China Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 39. China Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 40. China Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 41. Japan Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 42. Japan Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 43. Japan Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 44. Japan Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 45. India Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 46. India Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 47. India Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 48. India Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 49. South Korea Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 50. South Korea Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 51. South Korea Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 52. South Korea Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 53. Taiwan Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 54. Taiwan Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 55. Taiwan Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 56. Taiwan Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 57. Australia Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 58. Australia Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 59. Australia Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 60. Australia Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 65. Europe Cartilage Regeneration Technology, by Country USD Million (2015-2020)
  • Table 66. Europe Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 67. Europe Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 68. Europe Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 69. Europe Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 70. Germany Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 71. Germany Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 72. Germany Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 73. Germany Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 74. France Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 75. France Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 76. France Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 77. France Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 78. Italy Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 79. Italy Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 80. Italy Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 81. Italy Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 82. United Kingdom Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 83. United Kingdom Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 84. United Kingdom Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 85. United Kingdom Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 86. Netherlands Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 87. Netherlands Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 88. Netherlands Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 89. Netherlands Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 90. Rest of Europe Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 91. Rest of Europe Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 92. Rest of Europe Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 93. Rest of Europe Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 94. MEA Cartilage Regeneration Technology, by Country USD Million (2015-2020)
  • Table 95. MEA Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 96. MEA Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 97. MEA Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 98. MEA Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 99. Middle East Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 100. Middle East Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 101. Middle East Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 102. Middle East Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 103. Africa Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 104. Africa Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 105. Africa Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 106. Africa Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 107. North America Cartilage Regeneration Technology, by Country USD Million (2015-2020)
  • Table 108. North America Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 109. North America Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 110. North America Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 111. North America Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 112. United States Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 113. United States Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 114. United States Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 115. United States Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 116. Canada Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 117. Canada Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 118. Canada Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 119. Canada Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 120. Mexico Cartilage Regeneration Technology, by Application USD Million (2015-2020)
  • Table 121. Mexico Cartilage Regeneration Technology, by Treatment USD Million (2015-2020)
  • Table 122. Mexico Cartilage Regeneration Technology, by End Use USD Million (2015-2020)
  • Table 123. Mexico Cartilage Regeneration Technology, by Portion USD Million (2015-2020)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Cartilage Regeneration Technology: by Application(USD Million)
  • Table 131. Cartilage Regeneration Technology Hyaline Cartilage , by Region USD Million (2021-2026)
  • Table 132. Cartilage Regeneration Technology Fibrocartilage , by Region USD Million (2021-2026)
  • Table 133. Cartilage Regeneration Technology: by Treatment(USD Million)
  • Table 134. Cartilage Regeneration Technology Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors) , by Region USD Million (2021-2026)
  • Table 135. Cartilage Regeneration Technology Non-cell-based (Tissue Scaffolds, Cell-free Composites) , by Region USD Million (2021-2026)
  • Table 136. Cartilage Regeneration Technology: by End Use(USD Million)
  • Table 137. Cartilage Regeneration Technology Hospitals , by Region USD Million (2021-2026)
  • Table 138. Cartilage Regeneration Technology Specialty Clinics , by Region USD Million (2021-2026)
  • Table 139. Cartilage Regeneration Technology: by Portion(USD Million)
  • Table 140. Cartilage Regeneration Technology Knee , by Region USD Million (2021-2026)
  • Table 141. Cartilage Regeneration Technology Hip , by Region USD Million (2021-2026)
  • Table 142. Cartilage Regeneration Technology Ankle and Foot , by Region USD Million (2021-2026)
  • Table 143. Cartilage Regeneration Technology Other , by Region USD Million (2021-2026)
  • Table 144. South America Cartilage Regeneration Technology, by Country USD Million (2021-2026)
  • Table 145. South America Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 146. South America Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 147. South America Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 148. South America Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 149. Brazil Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 150. Brazil Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 151. Brazil Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 152. Brazil Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 153. Argentina Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 154. Argentina Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 155. Argentina Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 156. Argentina Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 157. Rest of South America Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 158. Rest of South America Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 159. Rest of South America Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 160. Rest of South America Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 161. Asia Pacific Cartilage Regeneration Technology, by Country USD Million (2021-2026)
  • Table 162. Asia Pacific Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 163. Asia Pacific Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 164. Asia Pacific Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 165. Asia Pacific Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 166. China Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 167. China Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 168. China Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 169. China Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 170. Japan Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 171. Japan Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 172. Japan Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 173. Japan Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 174. India Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 175. India Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 176. India Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 177. India Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 178. South Korea Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 179. South Korea Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 180. South Korea Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 181. South Korea Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 182. Taiwan Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 183. Taiwan Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 184. Taiwan Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 185. Taiwan Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 186. Australia Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 187. Australia Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 188. Australia Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 189. Australia Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 190. Rest of Asia-Pacific Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 194. Europe Cartilage Regeneration Technology, by Country USD Million (2021-2026)
  • Table 195. Europe Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 196. Europe Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 197. Europe Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 198. Europe Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 199. Germany Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 200. Germany Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 201. Germany Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 202. Germany Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 203. France Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 204. France Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 205. France Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 206. France Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 207. Italy Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 208. Italy Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 209. Italy Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 210. Italy Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 211. United Kingdom Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 212. United Kingdom Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 213. United Kingdom Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 214. United Kingdom Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 215. Netherlands Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 216. Netherlands Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 217. Netherlands Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 218. Netherlands Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 219. Rest of Europe Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 220. Rest of Europe Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 221. Rest of Europe Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 222. Rest of Europe Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 223. MEA Cartilage Regeneration Technology, by Country USD Million (2021-2026)
  • Table 224. MEA Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 225. MEA Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 226. MEA Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 227. MEA Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 228. Middle East Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 229. Middle East Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 230. Middle East Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 231. Middle East Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 232. Africa Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 233. Africa Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 234. Africa Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 235. Africa Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 236. North America Cartilage Regeneration Technology, by Country USD Million (2021-2026)
  • Table 237. North America Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 238. North America Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 239. North America Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 240. North America Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 241. United States Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 242. United States Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 243. United States Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 244. United States Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 245. Canada Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 246. Canada Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 247. Canada Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 248. Canada Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 249. Mexico Cartilage Regeneration Technology, by Application USD Million (2021-2026)
  • Table 250. Mexico Cartilage Regeneration Technology, by Treatment USD Million (2021-2026)
  • Table 251. Mexico Cartilage Regeneration Technology, by End Use USD Million (2021-2026)
  • Table 252. Mexico Cartilage Regeneration Technology, by Portion USD Million (2021-2026)
  • Table 253. Research Programs/Design for This Report
  • Table 254. Key Data Information from Secondary Sources
  • Table 255. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cartilage Regeneration Technology: by Application USD Million (2015-2020)
  • Figure 5. Global Cartilage Regeneration Technology: by Treatment USD Million (2015-2020)
  • Figure 6. Global Cartilage Regeneration Technology: by End Use USD Million (2015-2020)
  • Figure 7. Global Cartilage Regeneration Technology: by Portion USD Million (2015-2020)
  • Figure 8. South America Cartilage Regeneration Technology Share (%), by Country
  • Figure 9. Asia Pacific Cartilage Regeneration Technology Share (%), by Country
  • Figure 10. Europe Cartilage Regeneration Technology Share (%), by Country
  • Figure 11. MEA Cartilage Regeneration Technology Share (%), by Country
  • Figure 12. North America Cartilage Regeneration Technology Share (%), by Country
  • Figure 13. Global Cartilage Regeneration Technology share by Players 2020 (%)
  • Figure 14. Global Cartilage Regeneration Technology share by Players (Top 3) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. DePuy Synthes (United States) Revenue, Net Income and Gross profit
  • Figure 17. DePuy Synthes (United States) Revenue: by Geography 2020
  • Figure 18. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2020
  • Figure 20. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 21. Zimmer Biomet (United States) Revenue: by Geography 2020
  • Figure 22. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. CONMED Corporation (United States) Revenue: by Geography 2020
  • Figure 24. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 26. Vericel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Vericel Corporation (United States) Revenue: by Geography 2020
  • Figure 28. Global Cartilage Regeneration Technology: by Application USD Million (2021-2026)
  • Figure 29. Global Cartilage Regeneration Technology: by Treatment USD Million (2021-2026)
  • Figure 30. Global Cartilage Regeneration Technology: by End Use USD Million (2021-2026)
  • Figure 31. Global Cartilage Regeneration Technology: by Portion USD Million (2021-2026)
  • Figure 32. South America Cartilage Regeneration Technology Share (%), by Country
  • Figure 33. Asia Pacific Cartilage Regeneration Technology Share (%), by Country
  • Figure 34. Europe Cartilage Regeneration Technology Share (%), by Country
  • Figure 35. MEA Cartilage Regeneration Technology Share (%), by Country
  • Figure 36. North America Cartilage Regeneration Technology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • DePuy Synthes (United States)
  • Smith & Nephew plc (United Kingdom)
  • Zimmer Biomet (United States)
  • CONMED Corporation (United States)
  • Stryker Corporation (United States)
  • Vericel Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation